Product Information
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB is a generic product labeled by Quagen Pharmaceuticals LLC, priced at $0.5892 per EA under NDC 70752014810. Its NADAC has been published 93 times since Nov 13, 2024.
FDA first approved this application on Jan 18, 2024. Its Orange Book therapeutic-equivalence code is AA.
Strength
325; 50 mg/1; mg/1
Manufacturer
Quagen Pharmaceuticals LLCNDC
70752014810
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ACETAMINOPHEN; BUTALBITALApproval Type
Generic (ANDA)
FDA Application
ANDA214291FDA Approved
1/18/2024
TE Code
AA
On Market Since
5/1/2024
Pharmacological Classes
Price Statistics
The NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has been published 93 times since Nov 13, 2024, and over the history we have for it it has declined 11.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5892 per EA |
|---|---|
| All-time high | $0.7122 (Mar 11, 2026) |
| All-time low | $0.4121 (Nov 20, 2024) |
| 52-week high | $0.7122 |
| 52-week low | $0.5411 |
| Median price | $0.6219 |
| Average price | $0.6087 |
| Largest weekly change | -38.3% (Nov 20, 2024) |
| Weeks tracked | 93 |
| Tracking since | Nov 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the BUTALBITAL and ACETAMINOPHEN market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB, manufactured by Quagen Pharmaceuticals LLC, is $0.5892 per EA (NDC 70752014810), effective Aug 19, 2026.
How has the price of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB changed over time?
Over the history we have for it, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has declined 11.8%. It has been tracked across 93 weekly CMS publications since Nov 13, 2024.
What are the highest and lowest recorded NADAC prices for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
Since Nov 13, 2024, the NADAC for BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB has ranged from a low of $0.4121 (Nov 20, 2024) to a high of $0.7122 (Mar 11, 2026), with a median of $0.6219 per EA.
Are there cheaper alternatives to BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB?
BUTALBITAL-ACETAMINOPHEN 50-325 MG TAB (NDC 70752014810) is labeled by Quagen Pharmaceuticals LLC, and CMS classifies it as a generic product.